4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,125.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,820.00
  • 52 Week Low: 1,080.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 373
  • Market Cap: £174.33m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.21% above the market average86.21% above the market average86.21% above the market average86.21% above the market average86.21% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
97.36% above the market average97.36% above the market average97.36% above the market average97.36% above the market average97.36% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
54.23% below the market average54.23% below the market average54.23% below the market average54.23% below the market average54.23% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average
Price Chg 3m
16.87% below the market average16.87% below the market average16.87% below the market average16.87% below the market average16.87% below the market average
20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
54.57% below the market average54.57% below the market average54.57% below the market average54.57% below the market average54.57% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Momentum 20
94.78% below the market average94.78% below the market average94.78% below the market average94.78% below the market average94.78% below the market average
95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
93.21% below the market average93.21% below the market average93.21% below the market average93.21% below the market average93.21% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
47.86% below the market average47.86% below the market average47.86% below the market average47.86% below the market average47.86% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Operating Profit Loss
80.97% below the market average80.97% below the market average80.97% below the market average80.97% below the market average80.97% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
51.03% below the market average51.03% below the market average51.03% below the market average51.03% below the market average51.03% below the market average
6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average
Cash
32.53% below the market average32.53% below the market average32.53% below the market average32.53% below the market average32.53% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
16.86% above the market average16.86% above the market average16.86% above the market average16.86% above the market average16.86% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Buys 1y
70.03% above the market average70.03% above the market average70.03% above the market average70.03% above the market average70.03% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,125.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,820.00
52 Week Low 1,080.00
Volume 373
Shares Issued 15.50m
Market Cap £174.33m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.87% below the market average23.87% below the market average23.87% below the market average23.87% below the market average23.87% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
44.35% above the market average44.35% above the market average44.35% above the market average44.35% above the market average44.35% above the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average
Income Not Available
Growth
39.28% above the market average39.28% above the market average39.28% above the market average39.28% above the market average39.28% above the market average
43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average

4basebio Dividends

No dividends found

Trades for 02-May-2025

Time Volume / Share Price
16:18 341 @ 1,122.40p
08:00 10 @ 1,122.40p
08:00 22 @ 1,122.40p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page